Telehealth company eMed and Quest Diagnostics Inc (NYSE: DGX) have collaborated for clinician-guided rapid antigen testing for COVID-19 in workplaces. Through the collaboration, the two companie
Quest Diagnostics was the beneficiary of a faster than expected recovery in its base business in the second quarter.
Steve Rusckowski, Quest Diagnostics chairman and CEO, joins 'Closing Bell' to discuss the company's quarterly earnings, how much of the business remains coronavirus-related and the uptick in testing d
The sector's Q2 results are likely to reflect solid earnings and revenue growth on strong base business recovery.
Quest Diagnostics CEO Steve Rusckowski told CNBC the company is seeing an increase in Covid-19 tests, with the majority of positive results this week identified as the delta variant.
Quest Diagnostics Incorporated (DGX) CEO Steve Rusckowski on Q2 2021 Results - Earnings Call Transcript
According to Quest Diagnostics (DGX), Q2 is the first quarter since 2019 in which it has registered organic base testing revenue growth.
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 10.80% and 6.64%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Quest Diagnostics Inc. reported Thursday second-quarter adjusted profit that more than doubled to beat expectations, as revenue also topped forecasts, as the recovery in the lab results and diagnostic
SECAUCUS, N.J., July 22, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the s

Quest Diagnostics's Earnings: A Preview

10:38am, Wednesday, 21'st Jul 2021
Quest Diagnostics (NYSE:DGX) will be releasing its next round of earnings this Thursday, July 22. For all of the relevant information, here is your guide for Thursday's Q2 earnings announcement.
Quest Diagnostics' (DGX) COVID-19 testing will be available through TrustAssure platform for international travelers and live event attendants.
Quest Diagnostics' (DGX) second-quarter performance within its non-COVID base business might have registered significant sales rebound.
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SECAUCUS, N.J., July 14, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2021 Disability Equali
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE